| Gene symbol | DLL3 | Synonyms | SCDO1 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | delta like canonical Notch ligand 3 | ||||
| GTO ID | GTC3836 |
| Trial ID | NCT06348797 |
| Disease | Small Cell Lung Cancer |
| Altered gene | DLL3 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | CAR-T cell |
| Treatment | BHP01 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I Clinical Study on Safety and Feasibility of DLL3 Targeted α-PD-L1/4-1BB Modifying Chimeric Antigen Receptor T-cells in Patients With Relapsed or Refractory Small Cell Lung Cancer (SCLC) |
| Year | 2024 |
| Country | China |
| Company sponsor | Sichuan University |
| Other ID(s) | BHP01-01 |
| Cohort 1 | |||||||||||
|
|||||||||||